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Background: Malaria is one of the most important infectious diseases in the World. The choice for the treatment is
highly limited, and several of these may eventually be lost or compromised due to drug resistance. The use of plant
medicine in the treatment of malaria and its various presentations is a common practice in many countries of Africa
where the disease is mostly endemic. Dodonaea angustifolia is traditionally used in Ethiopia for prophylaxis against
malaria. The present study is attempted to evaluate the antimalarial activity of the solvent fractions of root extracts
of D. angustifolia in P. berghei infected mice.
Methods: In this study, 4-days Peter’s suppressive test was used to determine parasite inhibition. Acute toxicity test
was also conducted on the most active fraction according to Organization for Economic Cooperation and Development
(OECD) guidelines 425. Data was analyzed by using Windows SPSS version 16 and expressed as mean ± SD for each dose
level. ANOVA followed by Post Hoc Tukey’s HSD was used to compare result between treatment and control groups.
Students paired t-test was employed to test significance for the difference between initial and final results within the
same group.
Results: All three fractions showed varying degrees of antiplasmodial activity. The n-butanol fraction displayed a
relatively highest suppression of parasitaemia (67.51%) at an oral dose of 600 mg/kg. Lower doses, 200 mg/kg
and 400 mg/kg, of the fraction also resulted in parasitaemia suppression of 38.02% and 55.85%, respectively.
Chemosuppressive activity of chloroform and aqueous fractions was less compared to that of n-butanol fraction.
All the three fractions displayed dose dependent significant (P < 0.001) antiplasmodial activity as compared to
the control. Survival time was prolonged in case of n-butanol and chloroform fractions. No lethality to mice was
seen with n-butanol fraction up to a dose of 2000 mg/kg.
Conclusion: All the three fractions possessed significant antiplasmodial activity as compared with the control group.
n-butanol fraction was found to be the most active fraction with minimal toxicity and might contain potential
lead molecule for the development of a new drug for treatment of malaria.
Keywords: Malaria, Drug resistance, Dodonaea angustifolia, Plasmodium berghei and LD50Background
Malaria, a tropical blood-borne protozoan disease, is one
of the most important infectious diseases in the World
[1]. An estimated 3.3 billion of the total world population
live in areas with malaria risk [2] and an estimated death
of 660 000. Africa is the most affected continent: account-
ing for about 90% of all malaria deaths [3].* Correspondence: wote.amelo@ju.edu.et
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unless otherwise stated.Malaria control has relied on two arms namely control
of the anopheles mosquito vector and effective case
management [4]. For decades, drug resistance has been
one of the main obstacles in the fight against malaria [5]. It
is responsible for the spread of malaria to new areas, the re-
currence of malaria in areas where the disease had been
eradicated and plays an important role in the occurrence
and severity of epidemics in some parts of the World [1].
The choice of therapies for the treatment is highly limited,
and several of these may eventually be lost or compromisedLtd. This is an Open Access article distributed under the terms of the Creative
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of creating efficient vaccines and also adverse side-effects
of the existing anti-malarial drugs highlight the urgent
need for novel, well-tolerated anti-malarial drugs for both
prophylaxis and treatment of malaria [7].
According to several reports, up to 80% of world’s popu-
lations rely on traditional medicine mainly on herbal
remedies as primary source of medicinal agents for the
treatment of diseases [8]. The use of phytomedicine in
the treatment of malaria and its various presentations is
a common practice in many countries of Africa where
the disease is mostly endemic [9]. Some antimalarial drugs
in use today (quinine and artemisinin) were either obtained
from plants or developed using their chemical structures
as templates [10]. This explains why a lot of current re-
search focuses on natural molecules and plant-derived
products as they can be sourced easily, locally available and
can be selected on the basis of their ethnomedicinal use
[11]. In Ethiopia it is estimated that about 80% of the
Ethiopian population is still dependent on traditional
medicine, which essentially involves the use of plants [12].
Dodonaea angustifolia (Sapindaceae) commonly referred
to as Sand Olive, kitkita (Amharic), Hitacha (Afan Oromoo)
and itancha (Sidamu afoo). It is a shrub or small tree with
narrow shiny pale green leaves with a distinctive small
winged fruit [13]. It grows at the altitudes between 800 and
2650 m above sea level and in areas with a rainfall range of
500-1500 mm/year, commonly up to a height of 8 m. It
grows on dry rocky slopes between 1500 and 2100 m
throughout Ethiopia [13]. It also grows in a variety of
habitats and rapidly colonizes open areas of recently
cleared forests [14]. The genus Dodonaea comprises about
60 species [15]. The centre of origin of D. angustifolia is
believed to be Australia, but it is also widely distributed
throughout the tropics and subtropics [16].
The plant was selected on the basis of its use in folk
medicine for malaria treatment/prophylaxis and its prom-
ising antimalarial activity from previous in vitro and in vivo
studies. This plant has a wide range of therapeutic applica-
tions like pneumonia and other pulmonary diseases includ-
ing tuberculosis [16], analgesic and antipyretic effect [17].
In Ethiopia the plant is used for wound dressing, and for
treatment of skin diseases, fever, sore throat, rhinitis, sinus-
itis, and influenza [18] and also for prophylaxis against
malaria, bacteria and helminthes [19]. Different parts of
D. angustifolia has been reported to have significant
antimalarial activity, methanolic extract of root 84.52%
with 600 mg/kg dose [12], aqueous extract of seeds, 79.45%
with 1000 mg/kg dose [19], methanolic extract of leaves,
80.89% with 300 mg/kg dose [20].
D. angustifolia contains several secondary metabolites
like quinines, saponins, flavonoides, alkaloids, terpenoids,
diterpenoids, phenols and essential oils [12,16]. From the
studies conducted on the plant until now, it is known thatthe methanolic root extract of the plant has schizonticidal
activity as high as 84.52% [12]. Thus, the present study
aims at evaluating the invivo antiplasmodial activity of
solvent fractions of methanolic root extract of Dodonaea
angustifolia.
Methods
Collection of plant materials
The roots of Dodonaea angustifolia (Sapindaceae) was
collected from Chuko, Ethiopia. After botanical identifi-
cation, a voucher specimen, WA01/2011, was deposited
at the national herbarium, College of Natural Sciences,
Addis Ababa University.
Crude extract preparation and fractionation of the crude
extract
The collected plant materials were washed with distilled
water and air-dried at room temperature.
The plant material was then ground to powder using an
electrical grinding mill and kept till extracted with solvent.
The crude extract was prepared by cold maceration
technique, by refluxing 800 g of plant material in metha-
nol (98%). After 72 hrs the mixture was filtered using
Whatman filter paper. The extract was concentrated in a
rota vapor and stored in a refrigerator until fractionation.
The crude extract was in distilled water and Tween 80
(3%). Then the suspension was shaken in a separatory
funnel by adding n-butanol each time 3 times and the n-
butanol fraction was obtained. The aqueous residue was
then shaken with chloroform 3 times to obtain the chloro-
form fraction. The chloroform fraction was then treated
similarly as n- butanol fraction. The n-butanol and chloro-
form fractions were concentrated in rota vapor. The aque-
ous residue was also lyophilized to obtain the aqueous
fraction. Then the fractionations were kept in an amber
glass bottle and stored in a refrigerator.
Animal housing
Adult male Swiss albino mice (25- 32 g), aged 6- 8 weeks
were obtained from Ethiopian Health and Nutrition Re-
search Institute (EHNRI). The animals were kept in cages
and housed in a standard animal house under natural
12/12 h light dark cycle at room temperature. They were
maintained on standard pelleted diet and water ad libitum.
Before the experiment was started, they were all acclima-
tized to the test environment. The study protocol for
animal experiment was submitted to and approved by
the Ethics committee of the Department of Pharmacology,
School of Medicine. The animals were then randomly
assigned to the control and experimental groups.
In vivo anti-malarial sensitivity against P. berghei
Tests were performed in a 4-day suppressive standard
test [21]. Donor Plasmodium berghei infected mice were
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heart puncture. Then the blood was diluted with normal
saline so that each 0.2 ml contained approximately107
parasite infected erythrocytes [21]. The mice were divided
in to five groups of five in each for each fraction. Three
groups of mice received the fractions, while the other two
groups were used as standard and control groups.
On day 0 (before starting administration of the test sub-
stance and standard), mice of all groups were inoculated
intraperitoneally, with 0.2 ml of infected blood containing
about 1 × 107 parasitized red blood cells, which is expected
to produce steadily rising consistent infection of the re-
quired intensity in mice [21]. The mice in the test groups
received fractions of the extract once daily for 4 days.
The control group was administered with distilled water
and the standard group with chloroquine phosphate
(10 mg/kg) [21]. For each group of the animals 0.2 ml of
the preparation was administered and gavage was used for
oral administration.
On day 4 after infection, a thin smear of blood film
was taken from the peripheral blood of the tail of each
mouse in the test and control groups. The smears were
fixed with methanol and then stained with Giemsa stain.
Then, each stained slide was microscopically examined
under oil immersion of 1000 magnification (1000×) power
to evaluate the mean % of parasitaemia and suppression of
each fraction in comparison with control group. The mean
parasitaemia was calculated and expressed as follows [21]:
%Parasitemia ¼ Total number of Parasitized red blood cells
Total number of Red blood cells
 100%
Percentage parasitaemia suppression was calculated ac-
cording to the following formula [21]
Parasitaemia in control group‐ parasitaemia in study group
Parasitaemia in control group
 100
Determination of mean survival time
Mortality was monitored daily and the number of days
from the time of inoculation of the parasite up to death
was recorded for each mouse in all groups throughout
the follow up period. The mean survival time (MST) for
each group was calculated as follows [16]:
MST ¼ Sum of survival time of all mice in a group daysð Þ
Total number of mice in that group
Determination of packed cell volume
The packed cell volume (PCV) of each mouse was mea-
sured before infection and on day 4 after infection [22].
For this purpose, blood was collected from tail of each
mouse in heparinized microhaematocrit capillary tubes
up to 3/4th of their length. The tubes were sealed by
critoseal and placed in a microhaematocrit centrifuge(Gelman Hawksley, England) at 5000 rpm for 5 minutes.
Then the tubes were taken out from the centrifuge and
the result was read using microhaematocrit reader
(Gelman Hawksley, England) according to the following
formula [16]:




A pilot study was conducted to identify the most active
fraction and acute toxicity of the fraction was tested. Healthy
female swiss albino mice maintained under standard labora-
tory conditions were used for acute toxicity test according
to Organization for Economic Cooperation and Develop-
ment (OECD) guidelines. The acute toxicity studies were
conducted as per the OECD guidelines 425 [23] where the
limit test dose of 2000 mg/kg was used. They were all
observed for toxicity signs like changes in physical ap-
pearance, behavioral change, motor and feeding activities,
and other signs of acute toxicity and mortality after ad-
ministration of the dose.
Data analysis
To analyze data obtained during the experiment windows
SPSS version 16 was used and expressed as mean ± SD for
each dose level. ANOVA followed by Post Hoc Tukey’s
HSD was used to compare result between treatment and
control groups. Students paired t-test was employed to
test significance for the difference between initial and
final results within the same group. The result was con-




The n-butanol fraction was tolerated by the study mice
when administered orally. No death was observed in the
animals receiving the fraction up to a dose of 2000 mg/kg
body weight. This shows that the lethal dose (LD50) is
greater than 2000 mg/kg body weight.
Effect of fractions of methanolic root extract of Dodonaea
angustifolia on parasitemia and mean survival time
The results of the 4-day suppressive test of the n-butanol
fractions at different dose levels on parasitaemia and sur-
vival time in mice infected with Plasmodium berghei are
summarized in Table 1. The mice treated with CQ were
completely free from the parasites on day four. All mice
treated with the n-butanol fraction of methanolic root
extract of D. angustifolia significantly reduced parasit-
aemia level as compared to the control group (P < 0.001)
and the difference was also significant in comparison with
standard drug treated group. The fraction produced varying
Table 1 Effect of n-butanol fraction of methanolic root extract of D. angustifolia on percent parasitaemia and mean
survival time of the mice
Treatment Dose mg/kg %Parasitaemia %Chemosuppression Mean survival time
n-butanol fraction 200 34.02 ± 2.29 38.02c 10.33 ± 1.76a
400 24.24 ± 3.42 55.85c 10.79 ± 1.37a
600 17.83 ± 4.11 67.51c 11.37 ± 1.61b
Chloroquine 10 0 100 14.19 ± 0.84
Distilled water 1 ml 54.90 ± 4.39 0 7.79 ± 0.73
a = P < 0.05, b = P < 0.01, c = P < 0.001, parasitaemia and survival time expressed as mean ± SD, n = 5, the results are expressed as the percent suppression of
parasitaemia with reference to non-treated mice. distilled water = control.
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manner. The highest suppression (67.51%) was seen with
the dose of 600 mg/kg body weight. However the mice were
not completely cured from the infection in all treatment
doses but did significantly prolonged the mean survival time
at all dose levels (P < 0.05)
Significant reduction of parasitaemia (P < 0.001) was
observed in all groups of mice treated with chloroform
fractions of methanol root extract of D. angustifolia com-
pared with the control group (Table 2). The percent che-
mosuppression with the doses of 200, 400 and 600 mg/kg
body weight of the mice was 26.1, 36.6 and 42.00, respect-
ively (Table 3). The highest suppression was seen with the
dose of 600 mg/kg body weight of the mice.
The same table shows that the fraction also prolonged
the mean survival time of the study mice significantly
(P < 0.05) at 400 and 600 mg/kg body weight as compared
with the mice in control group.
The aqueous fraction suppressed parasitaemia signifi-
cantly at all dose levels (P < 0.001) as compared with the
control group (Table 3). The mean survival time, however,
did not significantly change with the aqueous fraction at
any of the dose levels.
Effect of fractions of methanolic root extract of D.
angustifolia on body weight
As shown in Table 4, a significant (p < 0.05) loss of body
weight was observed between days 0 and 4 in all fraction
treated groups. All the mice which received the three
fractions showed statistically significant difference (P < 0.05)Table 2 Effect of chloroform fraction of the methanolic root e
survival time of the mice
Treatment Dose mg/kg %Parasitemia
Chloroform fract. 200 40.58 ± 1.91
400 34.79 ± 0.50
600 31.85 ± 4.62
Chloroquine 10 0
Distilled water 1 ml 56.55 ± 8.38
a = P < 0.05, b = P < 0.01, c = P < 0.001, parasitaemia and survival time expressed as
parasitaemia with reference to non-treated mice, distilled water = control.in body weights at day 4 as compared with their weight
at day 0. Butanol fraction displayed significant differ-
ence in all doses as compared with control group, but
the difference was not significant in comparison with
standard drug treated group. Chloroform and aqueous
fractions showed no difference in comparison with both
control and standard drug treated group.
Effect of fractions of the methanolic root extract of D.
angustifolia on PCV
The effect of the fractions of the extract on PCV on days
0 and 4 is indicated in Figure 1. The aqueous fraction
showed significant difference (P < 0.01) in PCV as com-
pared with the standard drug treated group but no differ-
ence in comparison with untreated group. The difference
displayed by n-butanol and chloroform fractions was not
significant in comparison with standard drug (chloroquine)
treated group. Comparison of PCV at day 0 and day 4
indicated that all the three fractions did not prevent
PCV reduction (P < 0.05).
Discussion
Plants contain chemical constituents that have great po-
tential for medicinal use and both traditional healers and
pharmaceutical drug companies make use of these plants
[24]. The extracts of D. angustifolia were reported to
contain different classes of secondary metabolites such
as: tannins, alkaloids, quinines, saponins, flavonoides,
terpenoids, diterpenoids, phenols and essential oils [12,16].
Terpenoids, flavonoids saponins and alkaloids were knownxtract of D. angustifolia on parasitaemia and mean
%Chemosuppression Mean survival time
26.10c 8.96 ± 1.05
36.64c 9.99 ± 0.71a
42.00c 10.75 ± 2.16b
100 12.40 ± 0.54
0 7.63 ± 0.85
mean ± SD, n = 5, the results are expressed as the percent suppression of
Table 3 Effect of aqueous fraction of the methanolic root extract of D. angustifolia on parasitaemia and mean survival
time of the mice
Treatment Dose mg/kg %Parasitemia %Chemosuppression Mean survival time
Aq. fraction 200 48.79 ± 2.00 14.76c 7.40 ± 0.51
400 47.56 ± 1.56 16.91c 8.29 ± 0.83
600 45.23 ± 1.31 20.98c 8.58 ± 0.53
Chloroquine 10 0 100 12.84 ± 1.32
Distilled water 1 ml 57.24 ± 2.85 0 7.58 ± 0.53
c = p < 0.001, parasitaemia and survival time expressed as mean ± SD, n = 5, The results are expressed as the percent suppression of parasitaemia with reference to
non-treated mice.
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present in this plant which has antioxidant effect [27]
may also contribute to the antiplasmodial activity. An-
tioxidative activity can inhibit haem polymerization as
haem has to be oxidized before polymerization, and the
unpolymerized haem is very toxic for the intraerythrocytic
plasmodia [6]. These chemical compounds which are also
found in the fractions may be acting singly or in synergy
with one another to exert the observed antiplasmodial
activity of the fractions.
The n-butanol fraction did not show mortality within
24 hours up to a dose of 2000 mg/kg body weight indicat-
ing that the fraction is safe. In general, if the lethal dose
(LD50) of the test substance is three times more than the
minimum effective dose, the substance is considered a
good candidate for further studies [28]. This result is inTable 4 Effect of the fractions of methanolic root extract
of Dodonaea angustifolia on the body weight of the mice
Test substance Dose (mg/kg) Body weight (kg) %change
D-0 D-4
Butanol 200 30.42 ± 0.68 29.18 ± 0.21 -4.25c
400 29.84 ± 0.99 28.66 ± 0.44 -4.11c
600 28.70 ± 1.06 27.60 ± 0.34 -3.98a
Chloroquine 10 29.42 ± 2.17 29.04 ± 1.63 -1.30
Distilled water 1 ml 28.72 ± 0.77 25.74 ± 0.45 -11.58
Chloroform 200 29.74 ± 1.46 27.80 ± 1.92 -6.98
400 29.50 ± 1.75 27.06 ± 0.83 -9.02
600 29.56 ± 1.81 27.20 ± 1.10 -8.68
Chloroquine 10 29.38 ± 1.04 29.36 ± 1.32 -0.07
Distilled water 1 ml 30.34 ± 0.92 26.54 ± 1.39 -14.32
Aq. fraction 200 30.26 ± 1.30 28.18 ± 0.64 -7.38
400 30.98 ± 0.93 28.34 ± 0.42 -9.31
600 29.40 ± 2.32 27.36 ± 0.46 -7.46
Chloroquine 10 28.84 ± 1.39 28.46 ± 2.24 -1.34
Distilled water 1 ml 31.46 ± 0.83 27.06 ± 0.79 -16.26
a = P < 0.05, c = P < .001, Body weight expressed as mean ± SD, n = 5 the results
are expressed as the percent reduction of body weight with reference to day 0.
Distilled water = control, D0 = a day infection initiated, D4 = 5th day of infection.agreement with other studies done on the same plant
with crude extracts, indicating that no death was observed
with different dose levels, 1000 mg/kg body weight [19],
3000 mg/kg body weight [12] and 4500 mg/kg body
weight [16]. But abnormalities like depression, weakness
and rough hair coat was observed with 4500 mg/kg crude
methanolic extract of D. angustifolia [12].
The fractions from this study showed varying degrees
of antiplasmodial activity. The n-butanol fraction showed
a relatively highest suppression of parasitaemia (67.51%)
at an oral dose of 600 mg/kg (Tab 1). Administration of
200 mg/kg and 400 mg/kg doses to mice with also re-
sulted in parasitaemia suppression. All three test doses
displayed significant difference (P < 0.001) in comparison
with control group and the standard drug (chloroquine)
treated group. The activity may be due to the individual or
synergistic effect of the secondary metabolite found in the
fraction like alkaloids, saponins, flavonoids, tannins and
phenols [29-31]. The chloroform fraction also showed
significant (P < 0.001) antiplasmodial activity (Tab 2). The
fraction showed dose dependent chemosuppression. The
aqueous fraction similarly displayed a dose-dependent sup-
pressive activity (Tab 3). But the chemosupressive activity
of chloroform and aqueous fraction was, however, less as
compared with that of n-butanol fraction indicating the
difference in the type and concentration of the secondary
metabolites in the fractions. The same result was reported
from the study done on different plant but the same
solvents for fractionation [32]. This may be due to less
number of secondary metabolites that are active against
malaria parasites in aqueous fraction.
In this study the chemosuppressive activity of all three
fractions is lower than the activity obtained from other
studies of the same plant with the reported results of
crude methanolic extracts of leaves (80.89%) [20], crude
aqueous extracts of seed (79.45%) [19] and crude meth-
anolic extract of roots (84.52%) [12]. This finding is in
agreement with another study in which the crude ex-
tract of Cocholospermum tinctorum reported to show
better in vivo antimalarial activity than the fractions [33].
The reduction in activity of the crude extracts upon frac-
tionations could be explained by the loss of synergistic
Figure 1 Effect of fractions (A = butanol, B = chloroform and C = aqueous fraction) of the methanolic root extract of D. angustifolia on
PCV of P. berghei infected mice.
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by denaturation of the compounds during storage.
The n-butanol and chloroform fractions prolonged the
mean survival time of the study mice indicating that they
suppressed P. berghei and reduced the overall pathologic
effect of the parasite on the study mice. But all doses from
aqueous fraction were not able to significantly prolong the
mean survival time as compared with control group. This
may be due to the less schizoticidal activity of the fraction
as compared to the other two fractions.
Animals suffer from anemia because of red cell destruc-
tion, either by parasite multiplication or by spleen reticu-
loendotelial cell action [34]. In this study the n-butanol,
chloroform and aqueous fractions did not show protection
against reduction in PCV as compared with day 0 (Figure 1).
In untreated mice, the parasite count increased and the
PCV decreased markedly which was also observed in
previous studies [26,35].
Body weight loss is one feature of rodent malaria infec-
tions [16]. All the three fractions didn’t prevent weight re-
duction in the present study (Tab 4). This result is in
agreement with one of the previous studies on the crude
extracts of the same plant [16]. However, the result of the
present study on body weight is not in agreement with the
findings from the crude extracts of Asparagus africanus
[35] and butanol fraction of both crude aqueous and hydro-
alcoholic extract of C. myricoides [26] which preventedbody weight loss of P. berghei infected mice. The inconsist-
ency of the results might be due to variation in nutrient
content of the plants. The loss of body weight of the mice
treated with the fractions may possibly be due to the appe-
tite suppressive effect of the components in the fraction.Conclusion
From the present study it could be concluded that all the
three fractions possessed significant antiplasmodial activity
as seen in their ability to suppress P. berghei infection in
mice. Butanol fraction was found to be relatively the most
active fraction with minimal toxicity. So, the n-butanol
fraction might contain potential lead molecule for the
development of a new drug for treatment of malaria. The
present study confirmed the finding of previous studies
conducted on the same plant.
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